Insider · CIK 0001655366
Sandra Boenisch
Files at AVXL (ANAVEX LIFE SCIENCES CORP.). First filing -, latest -.
In brief
Sandra Boenisch files SEC Form 4 as CFO at AVXL (ANAVEX LIFE SCIENCES CORP.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Sandra Boenisch has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | AVXL ANAVEX LIFE SCIENCES CORP. | AGrant or award Stock Option (Right to Buy)derivative | +20,000 | $0.00 | $0 | 20,000 | 15 d ago |
| Sep 24, 2026 | AVXL ANAVEX LIFE SCIENCES CORP. | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | 15 d ago |
| Sep 24, 2026 | AVXL ANAVEX LIFE SCIENCES CORP. | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | 15 d ago |
| Sep 24, 2026 | AVXL ANAVEX LIFE SCIENCES CORP. | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | 15 d ago |
| Jan 6, 2026 | AVXL ANAVEX LIFE SCIENCES CORP. | AGrant or award Stock Option (Right to Buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Jan 9, 2026 |
| Oct 2, 2025 | AVXL ANAVEX LIFE SCIENCES CORP. | AGrant or award Stock Option (Right to Buy)derivative | +12,500 | $0.00 | $0 | 25,000 | Oct 3, 2025 |
| Aug 20, 2025 | AVXL ANAVEX LIFE SCIENCES CORP. | AGrant or award Stock Option (Right to Buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Aug 22, 2025 |
| Apr 28, 2025 | AVXL ANAVEX LIFE SCIENCES CORP. | AGrant or award Stock Option (Right to Buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Apr 30, 2025 |
| Jan 15, 2025 | AVXL ANAVEX LIFE SCIENCES CORP. | AGrant or award Stock Option (Right to Buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Jan 17, 2025 |
| Dec 19, 2024 | AVXL ANAVEX LIFE SCIENCES CORP. | AGrant or award Stock Option (Right to Buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Dec 23, 2024 |
| Nov 19, 2024 | AVXL ANAVEX LIFE SCIENCES CORP. | AGrant or award Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 20,000 | Dec 6, 2024 |
Questions about Sandra Boenisch
Answered from the filings on this page, as of the latest one.
Is Sandra Boenisch buying or selling?
Sandra Boenisch has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Sandra Boenisch's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sandra Boenisch has 0.
Where does Sandra Boenisch file Form 4?
Sandra Boenisch has filed Form 4 at AVXL (ANAVEX LIFE SCIENCES CORP.) as PFO & Treasurer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.